http://www.ausbiotech.org/directory/details.asp?companyid={FCDD472B-E719-46D0-80F2-F8EA1853E6D1}&returntourl=%2Fdirectory%2Fsearch.asp%3Fpg%3D9
BNE was formed in 2004 by a merge with Revenir Ltd. the company’s management has extensive experience in the management and control of biotechnology companies, drug delivery, clinical trials, product development, registration and business development. BNE is focussed on breakthrough treatments for bone and joint degeneration and disease, especially osteoporosis and arthritis. BNE aims to be a leading global development based company in musculo-skeletal therapies by 2012.
Looks like 2012 is the year for Bone.
GL to all.
- Forums
- ASX - By Stock
- Ann: Notice of General Meeting/Proxy Form
http://www.ausbiotech.org/directory/details.asp?companyid={FCDD47...
Featured News
Add BOT (ASX) to my watchlist
|
|||||
Last
34.5¢ |
Change
-0.020(5.48%) |
Mkt cap ! $543.4M |
Open | High | Low | Value | Volume |
35.5¢ | 35.5¢ | 34.0¢ | $4.566M | 13.13M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
11 | 410003 | 34.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
35.0¢ | 346713 | 8 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
9 | 403003 | 0.345 |
16 | 304864 | 0.340 |
12 | 887560 | 0.335 |
25 | 2286069 | 0.330 |
5 | 853843 | 0.325 |
Price($) | Vol. | No. |
---|---|---|
0.350 | 346713 | 8 |
0.355 | 48198 | 4 |
0.360 | 261992 | 7 |
0.365 | 522058 | 4 |
0.370 | 319527 | 7 |
Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
Featured News
BOT (ASX) Chart |
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online